Transferable exclusivity voucher: a flawed incentive to stimulate antibiotic innovation.

IF 98.4 1区医学 Q1 MEDICINE, GENERAL & INTERNAL

The Lancet Pub Date : 2024-01-13 Epub Date: 2023-02-09 DOI:10.1016/S0140-6736(23)00282-9

Christine Årdal, Enrico Baraldi, Reinhard Busse, Rosa Castro, Francesco Ciabuschi, José Miguel Cisneros, Inge C Gyssens, Stephan Harbarth, Tomislav Kostyanev, Yohann Lacotte, Nicola Magrini, Anthony McDonnell, Annelie A Monnier, Suerie Moon, Elias Mossialos, Germán Peñalva, Marie-Cécile Ploy, Momir Radulović, Adrián Alonso Ruiz, John-Arne Røttingen, Michael Sharland, Evelina Tacconelli, Ursula Theuretzbacher, Sabine Vogler, Ute Wolff Sönksen, Kerstin Åkerfeldt, Otto Cars, Jim O'Neill

引用次数: 0

查看原文本刊更多论文

可转让专有权凭证：激励抗生素创新的错误激励机制。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

The Lancet 医学-医学：内科

CiteScore

148.10

自引率

0.70%

发文量

2220

审稿时长

3 months

期刊介绍： The Lancet is a world-leading source of clinical, public health, and global health knowledge. It was founded in 1823 by Thomas Wakley and has been an independent, international weekly general medical journal since then. The journal has an Impact Factor of 168.9, ranking first among 167 general and internal medicine journals globally. It also has a Scopus CiteScore of 133·2, ranking it second among 830 general medicine journals. The Lancet's mission is to make science widely available to serve and transform society, positively impacting people's lives. Throughout its history, The Lancet has been dedicated to addressing urgent topics, initiating debate, providing context for scientific research, and influencing decision makers worldwide.